US Pharma MarketingGenetic medicines and more selective small molecules are finally pushing the field toward new mechanisms — and potentially disease-modifying treatments.
Epilepsy R&D is breaking out of its old playbook
Genetic medicines and more selective small molecules are finally pushing the field toward new mechanisms — and potentially disease-modifying treatments.
Source: PharmaVoice